Hangzhou Biotest Biotech Co., Ltd.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE1000050H0
CNY
37.98
0.96 (2.59%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
552.08
436.66
1,881.66
1,801.23
855.66
206.87
178.24
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
552.08
436.66
1,881.66
1,801.23
855.66
206.87
178.24
Raw Material Cost
272.16
231.20
891.72
695.52
219.76
121.07
112.70
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
95.14
90.53
168.08
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
1.85
0.84
1.19
1.36
1.00
1.19
1.36
Selling and Distribution Expenses
81.06
71.16
73.67
71.45
63.65
37.51
32.54
Other Expenses
-3.34
-1.09
-6.11
6.06
4.03
1.57
0.83
Total Expenditure (Excl Depreciation)
416.80
382.84
1,073.60
828.89
324.73
175.43
154.90
Operating Profit (PBDIT) excl Other Income
135.29999999999998
53.8
808.1
972.3000000000001
530.9000000000001
31.400000000000002
23.3
Other Income
83.86
119.52
169.18
8.34
-10.71
4.16
5.33
Operating Profit (PBDIT)
218.98
152.62
945.13
979.78
520.92
38.42
28.07
Interest
1.85
0.84
1.19
1.36
1.00
1.19
1.36
Exceptional Items
1.84
-6.16
-18.71
0.84
-0.00
-0.01
-0.01
Gross Profit (PBDT)
279.92
205.46
989.94
1,105.71
635.90
85.80
65.54
Depreciation
22.72
29.28
23.33
10.63
5.59
4.95
4.16
Profit Before Tax
196.24
116.34
901.90
968.63
514.33
32.27
22.53
Tax
28.14
10.58
128.33
132.87
79.36
4.33
3.68
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
169.52
106.61
773.63
833.59
435.15
28.23
18.91
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
169.52
106.61
773.63
833.59
435.15
28.23
18.91
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-2.74
-1.31
-0.07
2.17
-0.18
-0.29
-0.05
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
166.78
105.30
773.56
835.76
434.97
27.94
18.85
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
2,409.48
2,415.24
2,561.24
2,107.10
444.14
126.96
98.86
Earnings per share (EPS)
1.16
0.72
5.18
5.58
2.91
0.19
0.13
Diluted Earnings per share
1.16
0.72
5.18
5.58
2.91
0.19
0.13
Operating Profit Margin (Excl OI)
20.36%
0.87%
40.0%
53.34%
61.48%
14.17%
10.42%
Gross Profit Margin
39.66%
33.35%
49.17%
54.37%
60.76%
17.99%
14.98%
PAT Margin
30.7%
24.41%
41.11%
46.28%
50.86%
13.65%
10.61%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 26.43% vs -76.79% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is 58.40% vs -86.39% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 308.16% vs -95.73% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is 125.00% vs -33.33% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has improved from Dec 2023

Compare Annual Results Of Hangzhou Biotest Biotech Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
552.08
0
552.08
Other Operating Income
0.00
0.00
0.00
Total Operating income
552.08
0
552.08
Raw Material Cost
272.16
0
272.16
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
95.14
0
95.14
Power Cost
0
0
0.00
Manufacturing Expenses
1.85
0
1.85
Selling and Distribution Expenses
81.06
0
81.06
Other Expenses
-3.34
0.00
-3.34
Total Expenditure (Excl Depreciation)
416.80
0
416.80
Operating Profit (PBDIT) excl Other Income
135.29
0.00
135.29
Other Income
83.86
0
83.86
Operating Profit (PBDIT)
218.98
0
218.98
Interest
1.85
0
1.85
Exceptional Items
1.84
0
1.84
Gross Profit (PBDT)
279.92
0
279.92
Depreciation
22.72
0
22.72
Profit Before Tax
196.24
0
196.24
Tax
28.14
0
28.14
Provisions and contingencies
0
0
0.00
Profit After Tax
169.52
0
169.52
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
169.52
0
169.52
Share in Profit of Associates
0
0
0.00
Minority Interest
-2.74
0
-2.74
Other related items
0.00
0.00
0.00
Consolidated Net Profit
166.78
0
166.78
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
2,409.48
0
2,409.48
Earnings per share (EPS)
1.16
0
1.16
Diluted Earnings per share
1.16
0
1.16
Operating Profit Margin (Excl OI)
20.36%
0%
0.00
20.36%
Gross Profit Margin
39.66%
0%
0.00
39.66%
PAT Margin
30.70%
0%
0.00
30.70%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 55.21 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 26.43% vs -76.79% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 16.68 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 58.40% vs -86.39% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 13.51 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 308.16% vs -95.73% in Dec 2023

Annual - Interest
Interest 0.18 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 125.00% vs -33.33% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 20.36%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has improved from Dec 2023